ST
BMY.RT

Sageworth Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Sageworth Trust’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed – – 298
2020
Q4 		$0 Hold
50
– – ﹤0.01% 223
2020
Q3 		$0 Hold
50
– – ﹤0.01% 367
2020
Q2 		$0 Hold
50
– – ﹤0.01% 368
2020
Q1 		$0 Hold
50
– – ﹤0.01% 217
2019
Q4 		$0 Buy
+50
New +$130 ﹤0.01% 213

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Sageworth Trust's BMY.RT Position: Q1 2021 in Review

Sageworth Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 50 shares.

Sageworth Trust first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Sageworth Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Sageworth Trust sold 50 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Sageworth Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Sageworth Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sageworth Trust's 13F filing for Q1 2021, filed 13 May 2021.